Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 09, 2026 | September 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units - 11SEC Table II · derivative / convertible security | Direct | 1,774 |
Reported balance
After 2026-09-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 1,774 · Balance 1,774 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: RSUs that vest September 9, 2027 F3: Not Applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest September 9, 2027
F3: Not Applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 11, 2026 17:42 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 11 · Derivative | 1,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000093 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,774 Underlying: Common Stock · 1,774 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest September 9, 2027 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 10 · Derivative | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000086 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000086 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 16:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 7,093 | $112.80 | $800,090.40 |
DisclosureSEC source: 0000724004-26-000085 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,834 F1 · kind: Represents shares sold directly in a private transaction to Siddhartha Kadia, Mesa President and CEO Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 16:10 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-25-000015 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,282 Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 10 · Derivative | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000007 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,784 Underlying: Common Stock · 2,784 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 9 · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000007 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000007 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2024 Filed Nov 25, 2024 16:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000030 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,878 Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 8 · Derivative | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000024 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000024 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 15:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 9 · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000016 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404 Underlying: Common Stock · 1,404 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| April 02, 2024 Filed Apr 3, 2024 13:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 450 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-24-000007 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 450 shares Expires 2024-04-02 F1 · derivative.exercise_date: NSOs that vest 1/5 on each anniversary date of the April 2, 2018 grant date F2 · derivative.expiration_date: NSOs that expired on April 2, 2024 Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 11:11 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000039 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,804 Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 11:11 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000039 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 44,780 F1 · shares: Represents a gift of shares to a spousal lifetime access trust Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 11:11 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000039 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,804 F1 · shares: Represents a gift of shares to a spousal lifetime access trust Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:06 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 8 · Derivative | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000032 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074 Underlying: Common Stock · 1,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 7 · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000024 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 754 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to acquire one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000024 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 17:38 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000017 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next anniversary dates F3 · derivative.expiration_date: Not applicable Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 17:38 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 6 | $135.55 | $813.30 |
DisclosureSEC source: 0001228924-23-000017 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,250 Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 17:38 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000017 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units -1 · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000013 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15 Underlying: Common Stock · 15 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next 4 anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 6 | $134.45 | $806.70 |
DisclosureSEC source: 0001228924-23-000013 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,241 Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000013 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 16:50 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 14,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000004 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 44,580 F1 · shares: Represents a gift of shares to a spousal lifetime access trust Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 16:50 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 14,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000004 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,232 F1 · shares: Represents a gift of shares to a spousal lifetime access trust Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 1,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000043 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,812 Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 6 · Derivative | 787 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000038 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: vested RSUs issued for Board of Director Services F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 787 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000038 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 18, 2022 19:16 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 7 · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000027 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Underlying: Common Stock · 754 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 15,000 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-22-000022 · primary_doc.xml · derivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450 Underlying: Common Stock · 15,000 shares Expires 2023-04-03 F2 · derivative.exercise_date: 1/5 exercisable on each of the first 5 anniversary dates of the 04/03/2017 grant date Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Options · Derivative | 3,576 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000022 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,450 Underlying: Common Stock · 3,576 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 15,000 | $122.66 | $1,839,900.00 |
DisclosureSEC source: 0001228924-22-000022 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 3,576 | $70.56 | $252,322.56 |
DisclosureSEC source: 0001228924-22-000022 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000010 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 14 | $185.70 | $2,599.80 |
DisclosureSEC source: 0001228924-22-000010 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,874 Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000010 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 800 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · derivative · entry 7 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,026 Underlying: Common Stock · 800 shares Expires 2023-04-01 F3 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | OtherIncentive Stock Option · Derivative | 201 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · derivative · entry 6 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,826 Underlying: Common Stock · 201 shares Expires 2023-04-01 F3 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | Exercise / conversionCommon Stock | 1,001 | $70.56 | $70,630.56 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 800 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · derivative · entry 7 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,026 Underlying: Common Stock · 800 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherIncentive Stock Option · Derivative | 201 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · derivative · entry 6 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,826 Underlying: Common Stock · 201 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,001 | $70.56 | $70,630.56 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | OtherNon Qualified Stock Options · Derivative | 5,192 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · derivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,027 Underlying: Common Stock · 5,192 shares Expires 2023-04-01 F3 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | SaleCommon Stock | 5,192 | $207.76 | $1,078,689.92 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,857 F1 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on February 25, 2021 Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:30 UTC Amendment | MESA LABORATORIES INC /CO/ @pvcnt2f · Entity 5221 | Exercise / conversionCommon Stock | 5,192 | $70.56 | $366,347.52 |
DisclosureSEC source: 0001228924-22-000009 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Options · Derivative | 5,192 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · derivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,027 Underlying: Common Stock · 5,192 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/2015 grant date Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 5,192 | $207.76 | $1,078,689.92 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,857 Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 13:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 5,192 | $70.56 | $366,347.52 |
DisclosureSEC source: 0001228924-22-000008 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.